Phosphorylation by C-Jun NH2-terminal Kinase 1 Regulates the Stability of Transcription Factor Sp1 During Mitosis

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2008 Jan 18

PMID 18199680

Citations 56

Authors

Jian-Ying Chuang

Yi-Ting Wang

Shiu-Hwa Yeh

Yi-Wen Liu

Wen-Chang Chang

Jan-Jong Hung

Affiliations

Soon will be listed here.

Abstract

The transcription factor Sp1 is ubiquitously expressed in different cells and thereby regulates the expression of genes involved in many cellular processes. This study reveals that Sp1 was phosphorylated during the mitotic stage in three epithelial tumor cell lines and one glioma cell line. By using different kinase inhibitors, we found that during mitosis in HeLa cells, the c-Jun NH(2)-terminal kinase (JNK) 1 was activated that was then required for the phosphorylation of Sp1. In addition, blockade of the Sp1 phosphorylation via inhibition JNK1 activity in mitosis resulted in the ubiquitination and degradation of Sp1. JNK1 phosphorylated Sp1 at Thr278/739. The Sp1 mutated at Thr278/739 was unstable during mitosis, possessing less transcriptional activity for the 12(S)-lipoxygenase expression and exhibiting a decreased cell growth rate compared with wild-type Sp1 in HeLa cells. In N-methyl-N-nitrosourea-induced mammary tumors, JNK1 activation provided a potential relevance with the accumulation of Sp1. Together, our results indicate that JNK1 activation is necessary to phosphorylate Sp1 and to shield Sp1 from the ubiquitin-dependent degradation pathway during mitosis in tumor cell lines.

Citing Articles

Role of post-translational modifications of Sp1 in cancer: state of the art.

Sun X, Xiao C, Wang X, Wu S, Yang Z, Sui B Front Cell Dev Biol. 2024; 12:1412461.

PMID: 39228402 PMC: 11368732. DOI: 10.3389/fcell.2024.1412461.

LPS inhibits TRIM65 expression in macrophages and C57BL/6J mouse by activating the ERK1/2 signaling pathway.

Zeng X, Deng X, Ni Y, Bi H, Jiang M, Wang D Exp Ther Med. 2023; 25(4):188.

PMID: 37021067 PMC: 10068263. DOI: 10.3892/etm.2023.11887.

UVB-mediated DNA damage induces matrix metalloproteinases to promote photoaging in an AhR- and SP1-dependent manner.

Kim D, Iwasaki A, Chien A, Kang S JCI Insight. 2022; 7(9).

PMID: 35316219 PMC: 9090247. DOI: 10.1172/jci.insight.156344.

Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression.

Young M, Chen Y, Wang S, Chang H, Yang W, Lee C J Biomed Sci. 2022; 29(1):3.

PMID: 35034634 PMC: 8762881. DOI: 10.1186/s12929-022-00787-1.

Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells.

Yang W, Wu A, Hsu T, Liou J, Lo W, Chang K Cell Death Dis. 2021; 12(10):884.

PMID: 34584069 PMC: 8479077. DOI: 10.1038/s41419-021-04182-w.

References

Suske G . The Sp-family of transcription factors. Gene. 1999; 238(2):291-300. DOI: 10.1016/s0378-1119(99)00357-1. View

Fuchs S, Adler V, Buschmann T, Yin Z, Wu X, Jones S . JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 1998; 12(17):2658-63. PMC: 317120. DOI: 10.1101/gad.12.17.2658. View

Su K, Yang X, Roos M, Paterson A, Kudlow J . Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem J. 2000; 348 Pt 2:281-9. PMC: 1221064. View

Davis R . Signal transduction by the JNK group of MAP kinases. Cell. 2000; 103(2):239-52. DOI: 10.1016/s0092-8674(00)00116-1. View

Wells L, Vosseller K, Hart G . Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science. 2001; 291(5512):2376-8. DOI: 10.1126/science.1058714. View

Tighe A, Johnson V, Albertella M, Taylor S . Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2001; 2(7):609-14. PMC: 1083941. DOI: 10.1093/embo-reports/kve127. View

Fojas de Borja P, Collins N, Du P, Azizkhan-Clifford J, Mudryj M . Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 2001; 20(20):5737-47. PMC: 125670. DOI: 10.1093/emboj/20.20.5737. View

Taatjes D, Naar A, Andel 3rd F, Nogales E, Tjian R . Structure, function, and activator-induced conformations of the CRSP coactivator. Science. 2002; 295(5557):1058-62. DOI: 10.1126/science.1065249. View

Milanini-Mongiat J, Pouyssegur J, Pages G . Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem. 2002; 277(23):20631-9. DOI: 10.1074/jbc.M201753200. View

10.

Kuranaga E, Kanuka H, Igaki T, Sawamoto K, Ichijo H, Okano H . Reaper-mediated inhibition of DIAP1-induced DTRAF1 degradation results in activation of JNK in Drosophila. Nat Cell Biol. 2002; 4(9):705-10. DOI: 10.1038/ncb842. View

11.

Su K, Roos M, Yang X, Han I, Paterson A, Kudlow J . An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem. 1999; 274(21):15194-202. DOI: 10.1074/jbc.274.21.15194. View

12.

Chu S, Ferro T . Sp1: regulation of gene expression by phosphorylation. Gene. 2005; 348:1-11. DOI: 10.1016/j.gene.2005.01.013. View

13.

Wong C, Barnes L, Dahler A, Smith L, Popa C, Serewko-Auret M . E2F suppression and Sp1 overexpression are sufficient to induce the differentiation-specific marker, transglutaminase type 1, in a squamous cell carcinoma cell line. Oncogene. 2005; 24(21):3525-34. DOI: 10.1038/sj.onc.1208372. View

14.

Abdelrahim M, Safe S . Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol. 2005; 68(2):317-29. DOI: 10.1124/mol.105.011825. View

15.

Kotsopoulos J, Medline A, Renlund R, Sohn K, Martin R, Hwang S . Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis. 2005; 26(9):1603-12. DOI: 10.1093/carcin/bgi117. View

16.

Safe S, Abdelrahim M . Sp transcription factor family and its role in cancer. Eur J Cancer. 2005; 41(16):2438-48. DOI: 10.1016/j.ejca.2005.08.006. View

17.

Stark M, Assaraf Y . Loss of Sp1 function via inhibitory phosphorylation in antifolate-resistant human leukemia cells with down-regulation of the reduced folate carrier. Blood. 2005; 107(2):708-15. DOI: 10.1182/blood-2005-07-2743. View

18.

Hung J, Wang Y, Chang W . Sp1 deacetylation induced by phorbol ester recruits p300 to activate 12(S)-lipoxygenase gene transcription. Mol Cell Biol. 2006; 26(5):1770-85. PMC: 1430254. DOI: 10.1128/MCB.26.5.1770-1785.2006. View

19.

Spengler M, Brattain M . Sumoylation inhibits cleavage of Sp1 N-terminal negative regulatory domain and inhibits Sp1-dependent transcription. J Biol Chem. 2006; 281(9):5567-74. DOI: 10.1074/jbc.M600035200. View

20.

He Y, Zhang W, Zhang R, Zhang H, Min W . SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J Biol Chem. 2006; 281(9):5559-66. DOI: 10.1074/jbc.M512338200. View